Skip to main content

Table 4 Secondary outcome measures for assessment of the effectiveness of AH treatment in South Croatia

From: Effectiveness of treatment of newly diagnosed hypertension in family medicine practices in South Croatia

Secondary outcome measures Urban area (n = 64) Rural area (n = 78) Island area (n = 71) P a
Initial treatment (n, %):
 Non-pharmacological 14 (21.9) 8 (10.3) 18 (25.4) 0.043
 Pharmacological 50 (78.1) 70 (89.7) 52 (73.2)
 No data 0 (0.0) 0 (0.0) 1 (1.4)
Prescribing first medication (n, %):
 Physician 51 (79.7) 74 (94.9) 62 (87.3) 0.020
 Medical specialist 13 (20.3) 4 (5.1) 8 (11.3)
 No data 0 (0.0) 0 (0.0) 1 (1.4)
Sick leave days beacause of arterial hypertension (mean, 95% CI)
 Total number of daysb 1.8 (0.0–4.2) 3.6 (0.0–10.0) 1.2 (0.0–2.6) 0.692c
Proportion (n, %) of patients with prescribed medications from the List(s)d
 Basic 35 (64.8) 49 (70.0) 36 (60.0) 0.286
 Supplementary 11 (20.4) 6 (8.6) 9 (15.0)
 Basic + Supplementary 8 (14.8) 15 (21.4) 15 (25.0)
Total price for DDD per patient (median, HRK, interquartile range)e
 Total price for DDD 0.91 (0.49–1.24) 0.96 (0.45–1.55) 1.19 (0.49–2.06) 0.228f
  1. aχ2 test
  2. bCalculated only for employed patients
  3. cANOVA
  4. dExcluded participants without pharmacological treatment during the first treatment year (n = 16) and with incomplete data on medications required for analysis (n = 13)
  5. eThe median of all calculated sums of prices for defined daily dose (DDD) in Croatian kuna (HRK) of all medications prescribed to each patient during one-year treatment. Excluded participants without pharmacological treatment during the first treatment year (n = 16) and with incomplete data on medications required for analysis (n = 13)
  6. fKruskal-Wallis test